Rate My Professor Santosh Rudrawar

Dr. Santosh Rudrawar is an Associate Professor in the School of Pharmacy and Medical Sciences within Griffith Health at Griffith University and serves as a Research Leader at the Institute for Biomedicine and Glycomics. He earned his PhD in 2008 from the National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, India. Rudrawar was awarded an ARC Discovery Early Career Researcher Award (DECRA, DE140101632) and held an ARC Future Fellowship from 2014 to 2018 at Griffith University for the project 'Development of Innovative Chemical Tools for Studying Glycosyltransferases' within the School of Pharmacy and Medical Sciences. He returned to Griffith University in 2016 as a Lecturer, advancing to Senior Lecturer and subsequently to his current position as Associate Professor.

His research specializes in medicinal and organic chemistry, focusing on drug discovery and development for infectious diseases, neurodegeneration, and glycomics-related targets. Key contributions include the synthesis of novel sialic acid derivatives that lock open the 150-loop of an influenza A virus group-1 sialidase (Nature Communications, 2010, 130 citations), bisubstrate uridine-mimetic-peptide conjugates as inhibitors of human O-GlcNAc transferase (2020), and simplified novel muraymycin analogues using a serine protease (ChemMedChem, 2020). Highly cited works encompass magnesium perchlorate as an efficient catalyst for imine and phenylhydrazone synthesis (2004, 267 citations), 'on water' organic synthesis of benzothiazoles (2007, 227 citations), and liposomal doxorubicin as a targeted delivery platform (2021, 158 citations). With over 1,500 citations across 58 publications, his research demonstrates substantial impact in synthetic organic chemistry and pharmaceutical sciences. Rudrawar leads the integration of clinically relevant medicinal chemistry content in Bachelor of Pharmacy programs accredited by the Australian Pharmacy Council and supervises higher degree research students. He has secured significant funding, including a Griffith University Discovery Project grant valued at $767,243 in 2024 for 'Breaking the Cycle.' His professional activities include contributions to HDR career development sessions.